In vivo murine tumor gene delivery and expression by systemic recombinant vaccinia virus encoding interleukin-1β

Cancer Journal from Scientific American

Volumn 2, Issue 1, 1996, Pages 21-27

  Peplinski, Gary R ^a   Tsung, Kangla ^a   Casey, Matthew J ^a   Meko, Jennifer B ^a   Fredrickson, Torgny N ^c   Buller, R Mark L ^b   Norton, Jeffrey A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAINT LOUIS UNIVERSITY   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Gene therapy; Human interleukin 1 ; Murine; Pancreas cancer; Vaccinia

Indexed keywords

INTERLEUKIN 1; RECOMBINANT PROTEIN;

ANIMAL; ARTICLE; C57BL MOUSE; EXPERIMENTAL NEOPLASM; GENE EXPRESSION; GENE THERAPY; GENE VECTOR; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER; METHODOLOGY; MOUSE; PANCREAS TUMOR; PATHOLOGY; SPLEEN; VACCINIA VIRUS; VIROLOGY;

ANIMALS; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1; LIVER; MICE; MICE, INBRED C57BL; NEOPLASMS, EXPERIMENTAL; PANCREATIC NEOPLASMS; RECOMBINANT PROTEINS; SPLEEN; VACCINIA VIRUS;

EID: 0001894117     PISSN: 10814442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Jolly D. Viral vector systems for gene therapy. Cancer Gene Ther 1994;1:51-64.
2. Panicali D, Paoletti E. Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus. Proc Natl Acad Sci USA 1982;79:4927-4931.
3. Mackett M, Smith GL, Moss B. Vaccinia virus: a selectable eukaryotic cloning and expression vector. Proc Natl Acad Sci USA 1982;79:7415-7419.
4. Moss B. Poxvirus expression vectors. Curr Top Microbiol Immunol 1992;158:25-38.
5. Peplinski GR, Tsung K, Whitman ED, Meko JB, Norton JA. Construction and expression in tumor cells of a recombinant vaccinia virus encoding human interleukin-1β. Ann Surg Oncol 1995;2:151-159.
6. Smith GL, Moss B. Infectious poxvirus vectors have capacity for at least 25,000 base pairs of foreign DNA. Gene 1983;25:21-28.
7. Earl PL, Moss B. Protein expression IV: expression of proteins in mammalian cells using vaccinia. In: Ausubel FM, Brent R, Kingston RE et al, eds. Current Protocols in Molecular Biology. New York: Greene Publishing and Wiley-Interscience, 1991:16.15.1-16.18.10.
8. Buller RML, Smith GL, Cremer K, Notkins AL, Moss B. Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype. Nature 1985;317:813-815.
9. Ebina T, Murata K. Antitumor effector mechanism of interleukin-1β at a distant site in the double grafted tumor system. Jpn J Cancer Res 1991;82:1292-1298.
10. Belardelli F, Proietti E, Ciolli V et al. Interleukin-1β induces tumor necrosis and early morphologic and metabolic changes in transplantable mouse tumors. Similarities with the anti-tumor effects of tumor necrosis factor α or β. Int J Cancer 1989;44:116-123.
11. Neville ME, Pezzella KM, Schmidt K, Galbraith W, Ackerman N. In vivo inhibition of tumor growth of B16 melanoma by recombinant interleukin 1β. II. Mechanism of inhibition: the role of polymorphonuclear leukocytes. Cytokine 1990;2:456-463.
12. Young PR, Hazuda DJ, Simon PL. Human interleukin 1β is not secreted from hamster fibroblasts when expressed constitutively from a transfected cDNA. J Cell Biol 1988;107:447-456.
13. Kostura MJ, Tocci MJ, Limjuco G et al. Identification of a monocyte specific pre-interleukin β convertase activity. Proc Natl Acad Sci USA 1989;86:5227-5231.
14. Pecceu F, Dousset P, Shire D et al. Human interleukin 1β fused to the human growth hormone signal peptide is N-glycosylated and secreted by Chinese hamster ovary cells. Gene 1991;97:253-258.
15. Mims CA. The response of mice to the intravenous injection of cowpox virus. Brit J Exp Pathol 1968;49:24-32.
16. Lee SS, Eisenloht LC, McCue PA, Mastrangelo MJ, Lattime EC. Intravesical gene therapy: in vivo gene transfer using recombinant vaccinia virus vectors. Cancer Res 1994;54:3325-3328.
17. Acres B, Dott K, Stefani L, Kieny MP. Directed cytokine expression in tumour cells in vivo using recombinant vaccinia virus. Therapeutic Immunol 1994;1:17-23.
18. Paweletz N, Knierim M. Tumor-related angiogenesis. Crit Rev Oncol/Hematol 1989;9:197-242.
19. Dvorak HF, Nagy JA, Dvorak JT, Dvorak AM. Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. Am J Pathol 1988;133:95-109.
20. Buller RML, Palumbo GJ. Safety and attenuation of vaccinia virus. In: Binns MM, Smith GL, eds. Recombinant Poxviruses. Boca Raton, Fla: CRC Press, 1992:235-267.
21. Giavazzi R, Garofalo A, Bani MR et al. Interleukin 1-induced augmentation of experimental metastases from a human melanoma in nude mice. Cancer Res 1990;50:4771-4775.
22. Vidal-Vanaclocha F, Amezaga C, Asumendi A, Kaplanski G, Dinarello CA. Interleukin-1 receptor blockade reduces the number and size of B16 melanoma hepatic metastases. Cancer Res 1994;54:2667-2672.
23. Saito S, Bannerji R, Gansbacher B et al. Immunotherapy of bladder cancer with cytokine gene-modified tumor vaccines. Cancer Res 1994;54:3516-3520.
24. Peplinski GR, Tsung K, Meko JB, Norton JA. In vivo gene therapy of a murine pancreas tumor with recombinant vaccinia virus encoding human interleukin-1β. Surgery 1995;118:185-19.